Abiopharma

🔍 Willis Austin Chandler (Executive)

Company: WILLIS LEASE FINANCE CORP (WLFC)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 800 shares of Common Stock at $191.2231 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 158,080.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,484 shares of Common Stock at $192.7387 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 156,596.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 716 shares of Common Stock at $193.6308 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 155,880.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 400 shares of Common Stock at $194.43 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: false | shares_owned_after: 155,480.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Son | shares_owned_after: 1,822.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Daughter | shares_owned_after: 1,822.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Brother | shares_owned_after: 22,322.00 | Footnotes: F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Austin C. Willis 2019 Irrevocable Trust | shares_owned_after: 3,449.00 | Footnotes: F8
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: CFW V 2016 Trust | shares_owned_after: 8,692.00 | Footnotes: F9
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: 2019 Willis Family Trust | shares_owned_after: 232,715.00 | Footnotes: F10
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: CFW Partners | shares_owned_after: 405,488.00 | Footnotes: F12

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $190.97 to $191.61, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
• F3: This transaction was executed in multiple trades at prices ranging from $192.17 to $193.15, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.
• F4: This transaction was executed in multiple trades at prices ranging from $193.28 to $194.13, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.
• F5: Rooster A. Willis 2019 Trust, Austin Willis Trustee.
• F6: Wilder Grace Willis 2019 Trust, Austin Willis Trustee.
• F7: Charles F. Willis V 2019 Trust, Austin Willis Trustee.
• F8: Austin C. Willis 2019 Irrevocable Trust, Mary Willis Trustee.
• F9: Charles F. Willis V 2016 Trust, Austin Willis Trustee.
• F10: 2019 Willis Family Trust, Austin Willis Trustee.
• F11: Includes 213,415 shares having shared voting power of CFW Partners with Charles F. Willis IV.
• F12: Shared voting power of CFW Partners with Charles F. Willis IV.